Mural Oncology Balance Sheet Health
Financial Health criteria checks 6/6
Mural Oncology has a total shareholder equity of $234.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $263.5M and $28.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$231.67m |
Equity | US$234.93m |
Total liabilities | US$28.58m |
Total assets | US$263.50m |
Financial Position Analysis
Short Term Liabilities: MURA's short term assets ($239.4M) exceed its short term liabilities ($21.2M).
Long Term Liabilities: MURA's short term assets ($239.4M) exceed its long term liabilities ($7.3M).
Debt to Equity History and Analysis
Debt Level: MURA is debt free.
Reducing Debt: MURA had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MURA has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: MURA has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 7% each year.